1. |
Lloyd RV, Erickson LA, Jin L, et al. p27KIP1, a multifunctional cyclindependent kinase inhibitor with prognostic significance in human cancers [J]. Am J Pathol, 1999; 154(2)∶ 313.
|
2. |
Peng D, Fan Z, Lu Y, et al. Antiepidexmal growth factor receptor monoclonal antibody 225 upregulates p27KIP1and induces G1 arrest in prostatic cancer cell line DU1451 [J]. Cancer Res, 1996; 56(16)∶ 3666.
|
3. |
Polyak K, Kato JY, Solomon MJ, et al. p27KIP1, a cyclinCDK inhibitor; links transforming growth factorbeta and contact inhibition to cell cycle arrest [J]. Genes Dey, 1994; 8(1)∶ 9.
|
4. |
郭貴龍,姚榛祥. p27在甲狀腺濾泡狀腫瘤中的表達及其意義 [J]. 中國普外基礎與臨床雜志, 2001; 8(5)∶ 324.
|
5. |
夏加增,楊繼昌,張熔熔,等. 胃癌中cyclin D1、cyclin E和p27的表達及其意義 [J]. 中國普外基礎與臨床雜志, 2001; 8(3)∶ 148.
|
6. |
Tsihlias J, Kapusta LR, DeBoer G, et al. Loss of cyclindependent kinase inhibitor p27KIP1 is a novel prognostic factor in localized human prostate adenocarcinoma [J]. Cancer Res, 1998; 58(3)∶ 542.
|
7. |
Kawamata N, Morosetti R, Miller CW, et al. Molecular analysis of the cyclindependent kinase inhibitor gene p27/Kip1 in human malignancies [J]. Cancer Res, 1995; 55(11)∶ 2266.
|
8. |
Zhang Y, Lin SC. Molecular characterization of the cyclindependent kinase inhibitor p27 promoter [J]. Biochim Biophys Acta, 1997; 1353(3)∶ 307.
|
9. |
Loda M, Cukor B, Tam SW, et al. Increased proteasomedependent degradation of the cyclindependent kinase inhibitor p27 in aggressive colorectal carcinomas [J]. Nat Med, 1997; 3(2)∶ 231.
|